24 February 2016 - European regulators have approved Eli Lilly’s Portrazza as a treatment for patients with advanced non-small cell lung cancer.

For more details, go to: http://www.pharmatimes.com/Article/16-02-24/EU_green_light_for_Lilly_s_lung_cancer_drug_Portrazza.aspx